Michael Rome is Managing Director & Head of Therapeutics Investing at Foresite Capital, where he invests in therapeutics and broader biopharma/biotech across North America at stages from early (Series A) through later rounds (Series F). He serves on the boards of RayThera, Avenzo Therapeutics, Kinnate Biopharma Inc., Alumis, and Remix Therapeutics, and has invested in companies like CG Oncology, XinThera Inc., Affinivax Inc., Turning Point Therapeutics, and RayThera. Michael holds a Ph.D. in Biochemistry from Caltech and a B.S. in Molecular, Cellular and Developmental Biology from UCLA, and lives in Los Angeles.
Michael Rome, Managing Director @ Foresite. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Michael Rome from Foresite Capital. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Michael
Map your path to Michael instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Michael
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.